- Scholar Rock Holding Corporation (NASDAQ:SRRK) has priced its public offering of ~2,95M common shares at $39/share and, to certain investors, pre-funded warrants to purchase ~2.18M common shares at $38.9999/pre-funded warrant. Gross proceeds to be ~$200M.
- Underwriters' overallotment is an additional 769.23K common shares.
- Offering is expected to close on November 2.
- Net proceeds will be used to advance SRK-015 in Spinal Muscular Atrophy, including costs associated with preparing for and executing clinical trials (including a Phase 3 clinical trial), SRK-181 in cancer immunotherapy, development of its preclinical and discovery programs, as well as for working capital and other general corporate purposes.